Has Paul Jordan received payments from drug or device companies?

Yes. Drug and device makers reported $2,889 in general payments to Paul Jordan across 163 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Paul Jordan did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Paul Jordan come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Paul Jordan

Gastroenterology · Shreveport, LANPI 1801813613

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.7% of the total across 163 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by AbbVie at 31.4% of the total. Reporting peaked in 2019 at $1,554 and has fallen 96.8% since, to $50 in 2024. That places this record below the midpoint for gastroenterology clinicians in LA, where the typical reported total is $3,631.

$2,889in general payments, 2019–2025

Across 163 payments — averaging $17.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$908
Pfizer$431
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$430
Takeda Pharmaceuticals U.S.A., Inc.$359
Johnson & Johnson$245
Boston Scientific$143
plus $373 from 10 others

What the payments were for

Food & beverage$2,85099%
Education$110%
Gifts$271%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	45	$908
Pfizer	29	$431
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	26	$430
Takeda Pharmaceuticals U.S.A., Inc.	21	$359
Johnson & Johnson	18	$245
Boston Scientific	3	$143
UCB, Inc.	3	$64
ERBE USA Inc	1	$50
Intercept Pharmaceuticals, Inc.	3	$45
Shire North American Group Inc	2	$42
Dynavax Technologies Corporation	2	$39
Gilead	3	$38
Merck	2	$28
Braintree Laboratories, Inc.	2	$27
Cook Medical LLC	2	$25
QOL Medical, LLC	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Mavyret$115

How this compares

$2,889 in reported general payments places this provider in the 40th percentile of 254 gastroenterology providers in Louisiana.

See all gastroenterology providers in Louisiana →

Other gastroenterology in Shreveport

Humberto AguilarShreveport$313K
Hrishikesh SamantShreveport$81K
Sathya JaganmohanShreveport$25K
Qiang CaiShreveport$14K
Elvin HardyShreveport$13K
James MorrisShreveport$11K
John ProvenzaShreveport$9K
Jonathon ChapmanBaton Rouge$998K
Conar FittonKenner$955K
Gia LandryBaton Rouge$511K

See the full list for Louisiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →